|
|
Volumn 13, Issue 10, 2008, Pages 1272-1276
|
|
Drug regimens for visceral leishmaniasis in Mediterranean countries
a
e
EGE UNIVERSITY
(Turkey)
|
|
Author keywords
Amphotericin B; Leishmania infantum; Mediterranean visceral leishmaniasis; Miltefosine; Pentavalent antimony; Therapy
|
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B DEOXYCHOLATE;
AMPHOTERICIN B LIPID COMPLEX;
ANTILEISHMANIAL AGENT;
ANTIMONY;
MEGLUMINE ANTIMONATE;
MILTEFOSINE;
PAROMOMYCIN;
STIBOGLUCONATE SODIUM;
ANTIMONY;
DISEASE TREATMENT;
DRUG;
LEISHMANIASIS;
MEDITERRANEAN ENVIRONMENT;
AFRICA;
ARTICLE;
CHILL;
DOSE RESPONSE;
DRUG COST;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG SENSITIVITY;
DRUG USE;
ENDEMIC DISEASE;
FEVER;
HEALTH CARE COST;
HEART DISEASE;
HOSPITALIZATION;
HUMAN;
ISRAEL;
LEISHMANIA DONOVANI;
LEISHMANIA INFANTUM;
MIDDLE EAST;
NEPHROTOXICITY;
PANCREATITIS;
PATIENT CARE;
RECOMMENDED DRUG DOSE;
SOUTHERN EUROPE;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT PLANNING;
UNSPECIFIED SIDE EFFECT;
VISCERAL LEISHMANIASIS;
ADOLESCENT;
ADULT;
AFRICA, NORTHERN;
AGED;
AGED, 80 AND OVER;
AMPHOTERICIN B;
ANIMALS;
ANTIMONY SODIUM GLUCONATE;
ANTIPROTOZOAL AGENTS;
CHILD;
CHILD, PRESCHOOL;
CLINICAL PROTOCOLS;
EUROPE;
FEMALE;
HUMANS;
IMMUNOCOMPROMISED HOST;
ISRAEL;
LEISHMANIASIS, VISCERAL;
MALE;
MEGLUMINE;
MIDDLE AGED;
MIDDLE EAST;
AFRICA;
ASIA;
EURASIA;
EUROPE;
MIDDLE EAST;
NORTH AFRICA;
SOUTHERN EUROPE;
LEISHMANIA INFANTUM;
|
|
EID: 53549086915
PISSN: 13602276
EISSN: 13653156
Source Type: Journal
DOI: 10.1111/j.1365-3156.2008.02144.x Document Type: Article |
|
Times cited : (62)
|
|
References (12)
|
